Loading clinical trials...
Loading clinical trials...
Treatment of Multiple Sclerosis With Copaxone (Glatiramer Acetate) and Albuterol
Conditions
Interventions
Glatiramer acetate
Albuterol
+1 more
Locations
1
United States
Brigham and Women's Hospital/Harvard Medical School
Boston, Massachusetts, United States
Start Date
November 1, 2001
Primary Completion Date
March 1, 2006
Completion Date
November 1, 2007
Last Updated
September 22, 2016
NCT07225504
NCT06276634
NCT06948110
NCT06342713
NCT06809192
NCT05359653
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions